Impact of Continuous P2Y12 Inhibition Tailoring in Acute Coronary Syndrome and Genetically Impaired Clopidogrel Absorption. [electronic resource]
Producer: 20200930Description: 174-179 p. digitalISSN:- 1533-4023
- ATP Binding Cassette Transporter, Subfamily B -- genetics
- Acute Coronary Syndrome -- blood
- Aged
- Blood Platelets -- drug effects
- Clopidogrel -- administration & dosage
- Drug Monitoring
- Female
- Gastrointestinal Absorption -- genetics
- Humans
- Male
- Middle Aged
- Pharmacogenomic Variants
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- administration & dosage
- Purinergic P2Y Receptor Antagonists -- administration & dosage
- Randomized Controlled Trials as Topic
- Receptors, Purinergic P2Y12 -- blood
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.